Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' TAUSCHER J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 43 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tauscher, J; Kapur, S
      Choosing the right dose of antipsychotics in schizophrenia - Lessons from neuroimaging studies

      CNS DRUGS
    2. Frey, R; Heiden, A; Scharfetter, J; Schreinzer, D; Blasbichler, T; Tauscher, J; Felleiter, P; Kasper, S
      Inverse relation between stimulus intensity and seizure duration: Implications for ECT procedure

      JOURNAL OF ECT
    3. Kasper, S; Tauscher, J; Heiden, A
      Quetiapine: efficacy and tolerability in schizophrenia

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    4. Tauscher, J; Verhoeff, NPLG; Christensen, BK; Hussey, D; Meyer, JH; Kecojevic, A; Javanmard, M; Kasper, S; Kapur, S
      Serotonin 5-HT1A receptor binding potential declines with age as measured by [C-11]WAY-100635 and PET

      NEUROPSYCHOPHARMACOLOGY
    5. Willeit, M; Stastny, J; Pirker, W; Praschak-Rieder, N; Neumeister, A; Asenbaum, S; Tauscher, J; Fuchs, K; Sieghart, W; Hornik, K; Aschauer, HN; Brucke, T; Kasper, S
      No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism

      BIOLOGICAL PSYCHIATRY
    6. Tauscher, J; Pirker, W; Willeit, M; de Zwaan, M; Bailer, U; Neumeister, A; Asenbaum, S; Lennkh, C; Praschak-Rieder, N; Brucke, T; Kasper, S
      [I-123] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa

      BIOLOGICAL PSYCHIATRY
    7. Tauscher, J; Bagby, RM; Javanmard, M; Christensen, BK; Kasper, S; Kapur, S
      Inverse relationship between serotonin 5-HT1A receptor binding and anxiety: a [C-11]WAY-100635 PET investigation in healthy volunteers

      AMERICAN JOURNAL OF PSYCHIATRY
    8. Barnas, C; Quiner, S; Tauscher, J; Hilger, E; Willeit, M; Kufferle, B; Asenbaum, S; Brucke, T; Rao, ML; Kasper, S
      In vivo I-123 IBZM SPECT imaging of striatal dopamine 2 receptor occupancyin schizophrenic patients

      PSYCHOPHARMACOLOGY
    9. Verhoeff, NPLG; Meyer, JH; Kecojevic, A; Hussey, D; Lewis, R; Tauscher, J; Zipursky, RB; Kapur, S
      A voxel-by-voxel analysis of [F-18]setoperone PET data shows no substantial serotonin 5-HT2A receptor changes in schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    10. Pezawas, L; Quiner, S; Moertl, D; Tauscher, J; Barnas, C; Kufferle, B; Wolf, R; Kasper, S
      Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    11. Pirker, W; Asenbaum, S; Hauk, M; Kandlhofer, S; Tauscher, J; Willeit, M; Neumeister, A; Praschak-Rieder, N; Angelberger, P; Brucke, T
      Imaging serotonin and dopamine transporters with I-123-beta-CIT SPECT: Binding kinetics and effects of normal aging

      JOURNAL OF NUCLEAR MEDICINE
    12. Willeit, M; Praschak-Rieder, N; Neumeister, A; Pirker, W; Asenbaum, S; Vitouch, O; Tauscher, J; Hilger, E; Stastny, J; Brucke, T; Kasper, S
      [I-123]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder

      BIOLOGICAL PSYCHIATRY
    13. Tauscher, J; Tauscher-Wisniewski, S; Kasper, S
      Treatment of patients with delirium

      AMERICAN JOURNAL OF PSYCHIATRY
    14. Kasper, S; Tauscher, J; Kufferle, B; Barnas, C; Pezawas, L; Quiner, S
      Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    15. Tauscher, J; Pirker, W; de Zwaan, M; Asenbaum, S; Brucke, T; Kasper, S
      In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    16. Tauscher, J; Kufferle, B; Asenbaum, S; Fischer, P; Pezawas, L; Barnas, C; Tauscher-Wisniewski, S; Brucke, T; Kasper, S
      In vivo I-123 IBZM SPECT imaging of striatal dopamine-2 receptor occupancyin schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

      PSYCHOPHARMACOLOGY
    17. KASPER S; TAUSCHER J; KUFFERLE B; HESSELMANN B; BARNAS C; BRUCKE T
      IBZM-SPECT IMAGING OF DOPAMINE D-2 RECEPTORS WITH TYPICAL AND ATYPICAL ANTIPSYCHOTICS

      European psychiatry
    18. WILLEIT M; BARNAS C; TAUSCHER J; KUFFERLE B; KRENN P; ASENBAUM S; BRUCKE T; KASPER S
      VISUALIZATION OF DOPAMINE-2 RECEPTOR BLOCKADE IN PSYCHOTIC-PATIENTS TREATED WITH ZOTEPINE

      Schizophrenia research
    19. FISCHER P; TAUSCHER J; KUFFERLE B; KASPER S
      WEAK ANTIDEPRESSANT RESPONSE AFTER BUSPIRONE AUGMENTATION OF SEROTONIN REUPTAKE INHIBITORS IN REFRACTORY SEVERE DEPRESSION

      International clinical psychopharmacology
    20. FISCHER P; TAUSCHER J; KUFFERLE B
      RISPERIDONE AND TARDIVE-DYSKINESIA IN ORGANIC PSYCHOSIS

      Pharmacopsychiatry
    21. KASPER S; PRASCHAKRIEDER N; TAUSCHER J; WOLF R
      A RISK-BENEFIT ASSESSMENT OF MIRTAZAPINE IN THE TREATMENT OF DEPRESSION (VOL 17, PG 251, 1997)

      Drug safety
    22. Pearsall, R; Glick, ID; Pickard, D; Suppes, T; Tauscher, J; Jobson, KO
      A new algorithm for treating schizophrenia

      PSYCHOPHARMACOLOGY BULLETIN
    23. TAUSCHER J; FISCHER P; NEUMEISTER A; RAPPELSBERGER P; KASPER S
      LOW FRONTAL ELECTROENCEPHALOGRAPHIC COHERENCE IN NEUROLEPTIC-FREE SCHIZOPHRENIC-PATIENTS

      Biological psychiatry
    24. TAUSCHER J; PIRKER W; LENNKH C; DEZWAAN M; STRNAD A; BRUCKE T; KASPER S
      IN-VIVO VISUALIZATION OF SEROTONIN TRANSPORTERS DURING TREATMENT WITHSSRI

      Biological psychiatry
    25. TAUSCHER J; PIRKER W; LENNKH C; DEZWAAN M; STRNAD A; NEUMEISTER A; WILLEIT M; PRASCHAKRIEDER N; BRUCKE T; KASPER S
      ELEVATED BETA-CIT BINDING IN PATIENTS WITH BULIMIA-NERVOSA

      Biological psychiatry
    26. NEUMEISTER A; PRASCHAKRIEDER N; HESSELMANN B; VITOUCH O; RAUH M; BAROCKA A; TAUSCHER J; KASPER S
      EFFECTS OF TRYPTOPHAN DEPLETION IN DRUG-FREE DEPRESSED-PATIENTS WHO RESPONDED TO TOTAL SLEEP-DEPRIVATION

      Archives of general psychiatry
    27. KASPER S; TAUSCHER J; KUFFERLE B; BARNAS C; HESSELMANN B; ASENBAUM S; PODREKA I; BRUCKE T
      SERTINDOLE AND DOPAMINE D-2 RECEPTOR OCCUPANCY IN COMPARISON TO RISPERIDONE, CLOZAPINE AND HALOPERIDOL - A I-123 IBZM SPECT STUDY

      Psychopharmacology
    28. KASPER S; PRASCHAKRIEDER N; TAUSCHER J; WOLF R
      A RISK-BENEFIT ASSESSMENT OF MIRTAZAPINE IN THE TREATMENT OF DEPRESSION

      Drug safety
    29. NEUMEISTER A; PRASCHAKRIEDER N; HESSELMANN B; TAUSCHER J; KASPER S
      THE TRYPTOPHAN DEPLETION PARADIGM - METHO DS AND CLINICAL RELEVANCE

      Nervenarzt
    30. TAUSCHER J; NEUMEISTER A; FISCHER P; FREY R; KASPER S
      ELECTROCONVULSIVE-THERAPY IN THE CLINICAL -PRACTICE

      Nervenarzt
    31. TAUSCHER J; KUFFERLE B; BARNAS C; ASENBAUM S; BRUCKE T; KASPER S
      D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE, CLOZAPINE, RISPERIDONE AND HALOPERIDOL

      Biological psychiatry
    32. TAUSCHER J; KUFFERLE B; BARNAS C; ASENBAUM S; BRUCKE T; KASPER S
      PREMEDICATION INFLUENCED D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE AND SERTINDOLE

      Biological psychiatry
    33. WILLEIT M; PRASCHAKRIEDER N; ASENBAUM S; NEUMEISTER A; HESSELMANN B; HABELER A; IBATOULLINA E; TAUSCHER J; PIRKER W; BRUCKE T; KASPER S
      SEROTONIN TRANSPORTER DENSITY IN DEPRESSED SAD PATIENTS

      Biological psychiatry
    34. KASPER S; KUFFERLE B; TAUSCHER J; ASENBAUM S; BARNAS C; HESSELMANN B; PODREKA I; BRUCKE T
      DOPAMINE D-2 RECEPTOR-BINDING IN TYPICAL AND ATYPICAL NEUROLEPTICS

      Biological psychiatry
    35. KUFFERLE B; TAUSCHER J; ASENBAUM S; VESELY C; PODREKA I; BRUCKE T; KASPER S
      IBZM SPECT IMAGING OF STRIATAL DOPAMINE-2 RECEPTORS IN PSYCHOTIC-PATIENTS TREATED WITH THE NOVEL ANTIPSYCHOTIC SUBSTANCE QUETIAPINE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL

      Psychopharmacology
    36. TAUSCHER J; KUFFERLE B; ASENBAUM S; BRUCKE T; KASPER S
      PREVIOUS TREATMENT AS A CONFOUNDING VARIABLE IN STUDIES WITH NOVEL ANTIPSYCHOTICS - 2 CASES OF HIGH DOPAMINE-2 RECEPTOR OCCUPANCY WITH QUETIAPINE

      Psychopharmacology
    37. KUFFERLE B; BRUCKE T; TOPITZSCHRATZBERGER A; TAUSCHER J; GOSSLER R; VESELY C; ASENBAUM S; PODREKA I; KASPER S
      STRIATAL DOPAMINE-2 RECEPTOR OCCUPANCY IN PSYCHOTIC-PATIENTS TREATED WITH RISPERIDONE

      PSYCHIATRY RESEARCH-NEUROIMAGING
    38. KASPER S; TAUSCHER J
      NEW APPROACHES FOR PSYCHOPHARMACOLOGICAL TREATMENT

      Nervenheilkunde
    39. TAUSCHER J; KUFFERLE B; NEUMEISTER A; ASENBAUM S; BRUCKE T; PODREKA I; KASPER S
      IBZM-SPECT SHOWS LOW STRIATAL D2 BLOCKADE UNDER THERAPY WITH SEROQUEL

      Biological psychiatry
    40. KASPER S; TAUSCHER J; KUFFERLE B; HEIDEN A; NEUMEISTER A; BARNAS C; ASENBAUM S; PODREKA I; BRUCKE T
      D2 - RECEPTOR IMAGING (SPECT) AS A TOOL FOR MEASURING THE EFFICACY AND SIDE-EFFECT PROFILE OF TREATMENT WITH NEUROLEPTICS

      Biological psychiatry
    41. NEUMEISTER A; PRASCHAKRIEDER N; HESSELMANN B; TAUSCHER J; RAO ML; KASPER S
      THE ROLE OF THE SEROTONERGIC SYSTEM IN SEASONAL AFFECTIVE-DISORDER

      Biological psychiatry
    42. TAUSCHER J; RAPPELSBERGER P; NEUMEISTER A; KASPER S
      HYPOFRONTALITY IN DRUG-FREE SCHIZOPHRENIC-PATIENTS REVEALED BY EEG COHERENCE ANALYSIS

      Biological psychiatry
    43. TAUSCHER J; SCHINDLER S; RAPPELSBERGER P; KASPER S
      EEG CHANGES IN SCHIZOPHRENIC DISORDERS - A CRITICAL-REVIEW

      Fortschritte der Neurologie, Psychiatrie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 04:44:27